Artalejo C R, Elhamdani A, Palfrey H C
Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208, USA.
Neuron. 1996 Jan;16(1):195-205. doi: 10.1016/s0896-6273(00)80036-7.
Exocytosis and the ensuing rapid endocytosis in adrenal chromaffin cells are both Ca(2+)-dependent phenomena but differ in their divalent cation specificity, implying distinct Ca2+ receptors for the two processes. To ascertain whether calmodulin is the Ca2+ receptor for either process, we blocked its function by introducing calmodulin-binding peptides or anti-calmodulin antibodies into these cells. Exo/endocytosis was followed by measurement of cell membrane capacitance. Rapid endocytosis, but not exocytosis, was abolished by these treatments, indicating that calmodulin is the Ca2+ receptor for rapid endocytosis but is not involved in exocytosis. The principal calmodulin target is not protein phosphatase-2B, as antagonism of this enzyme did not inhibit but accelerated rapid endocytosis. Calmodulin may thus regulate both the rate and extent of rapid endocytosis by distinct pathways.
肾上腺嗜铬细胞中的胞吐作用以及随之而来的快速内吞作用都是依赖钙离子的现象,但它们在二价阳离子特异性方面存在差异,这意味着这两个过程有不同的钙离子受体。为了确定钙调蛋白是否是这两个过程中的钙离子受体,我们通过向这些细胞中引入钙调蛋白结合肽或抗钙调蛋白抗体来阻断其功能。通过测量细胞膜电容来跟踪胞吐/内吞作用。这些处理消除了快速内吞作用,但没有消除胞吐作用,表明钙调蛋白是快速内吞作用的钙离子受体,但不参与胞吐作用。主要的钙调蛋白靶点不是蛋白磷酸酶-2B,因为对该酶的拮抗作用并没有抑制反而加速了快速内吞作用。因此,钙调蛋白可能通过不同途径调节快速内吞作用的速率和程度。